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Hemophilia is a hereditary bleeding disorder which requires lifelong specialized care.  
A network of Hemophilia Treatment Centers (HTCs) exists to meet the medical needs of 
patients affected by hemophilia.  Genetic counseling services are an integral part of the HTC 
model of care; however, many HTCs do not have genetic counselors on staff.  As a result, the 
duty to provide these services must fall to other healthcare providers within the HTC.  To assess 
the knowledge and attitudes of these providers we developed a 49 question survey that was 
distributed electronically to hematologists and nurses at U.S. HTCs.  The survey consisted of a 
three sections: demographic information, knowledge of hemophilia genetics, and attitudes 
towards genetic services.  A total of 111 complete responses were received and analyzed.  The 
average knowledge score among all participants was 74.8% with a total of 81 participants 
receiving a passing score of 70% or above.  Thirty participants scored below 70% in the 
knowledge section.  In general, attitude scores were high indicating that the majority of 
hematologists and nurses in HTCs feel confident in their ability to provide genetic counseling 
services.  Over 90% of participants reported that they have some form of access to genetic 
counseling services at their center. 
  Hematologists and nurses practicing in U.S. HTCs demonstrate sufficient knowledge of 
the genetics of hemophilia, and they generally feel confident in their ability to provide genetic 
counseling services to their patients.  While their knowledge is sufficient, the average 
knowledge score was lower than 75%.  Certain questions covering new genetic technologies 
and testing practices were more commonly missed than questions asking about more basic 
aspects of hemophilia genetics, such as inheritance and carrier testing.  Finally, many clinics 
report having access to a counselor, but it is oftentimes a hematologist or nurse who is 
providing genetic counseling services to patients.  Given the inconsistency in knowledge among 
providers coupled with the high confidence in one’s ability to counsel patients, it leaves room to 
question whether information about the genetics of hemophilia is being communicated to 
patients in the most appropriate and accurate manner.  
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Background 
 
Hemophilia is a rare hereditary bleeding disorder characterized by a deficiency of either 
coagulation factor VIII or IX with bleeding symptoms that range in severity from mild to severe 
(1).  Complications associated with hemophilia include hemarthrosis, hematomas of the soft 
tissues, intracranial hemorrhages, prolonged bleeding, poor wound healing, prolonged oozing 
following minor injuries, epistaxis, and ecchymosis (2).  Due to the chronic nature and 
specialized treatment of the disorder, the Health Resources and Services Administration 
(HRSA) began funding a network of Hemophilia Treatment Centers (HTCs) in 1975 which 
employ a multidisciplinary approach to the management of hemophilia (3). 
There are over 140 registered HTCs across the United States (4) and each center is 
comprised of a core staff that includes a medical director, nurse coordinator, psychosocial 
professional, and physical therapist.  Some centers have additional providers on staff such as 
genetic counselors, orthopedists, and dentists (3).  The goals of HTCs are outlined by both the 
HRSA include: the provision of comprehensive care to patients and families affected by 
hereditary bleeding disorders, such as hemophilia; the provision of services to women, 
minorities, adolescents, the uninsured/underinsured, and people living in geographically 
underserved regions; the provision of outreach and education services; education emphasizing 
the importance of prevention of bleeding episodes; collaboration with other healthcare entities; 
and connection of patients to primary care physicians.  The Centers for Disease Control and 
Prevention (CDC) performs surveillances of outcomes and monitors blood safety in patients 
with hemophilia seen at HTCs. 
HTCs rely on a multidisciplinary approach to patient management which incorporates 
diagnosis, treatment, prevention and family education into its model of care.  HTCs provide 
healthcare services to 70-80% of individuals with hemophilia in the United States; and, in 2004, 
27,662 patients received services from HTCs in the United States, 15,224 of whom had 
hemophilia (5). 
Genetic counseling services are an essential component of the multidisciplinary care for 
patients with hemophilia.  Genetic counseling services at HTCs mainly consist of genetic 
education about the etiology, inheritance, recurrence risk, carrier screening, and genetic testing 
of hemophilia.  Among the 142 registered HTCs, the CDC reports that only 12 (8.5%) centers 
have a genetic counselor on staff (4).  Without a genetic counselor, the responsibility of 
providing genetic education to patients would likely fall to a physician, nurse, or social worker 
at the center. 
While several studies have assessed the knowledge and attitudes of healthcare providers 
toward genetic services, (6-11) there are no studies that have measured the genetics knowledge 
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of physicians and nurses in HTCs.  The objective of this study is to determine the level of 
genetics knowledge among physicians and nurses in HTCs, assess how genetic education is 
being provided to patients, and identify the attitudes towards and barriers for patients 
surrounding genetic counseling services in HTCs. 
 
Materials and Methods 
 
We developed a questionnaire, with permission, that was modeled after a validated tool 
originally created by Hofman et al. and used to assess the knowledge of genetics and genetic 
testing among family medicine physicians practicing in the United States (7).  The questionnaire 
used in this study was estimated to take 15-20 minutes to complete and was comprised of 49 
questions divided into three sections: 1) demographic information (14 questions), 2) knowledge 
of hemophilia genetics (14 questions), and 3) attitudes towards genetic services in an HTC (21 
questions).   The knowledge section consisted of multiple choice and true/false questions 
covering subjects such as heredity, genetic testing, prenatal/reproductive issues, and carrier 
screening as they apply specifically to hemophilia A.  In addition, an optional free response 
section was provided at the end of the questionnaire for participants who wished to include 
other comments.  The questionnaire was generated using the web-based REDCap software (12), 
and it was only available in electronic format.  The questionnaire and study design were 
approved by the Committee for the Protection of Human Subjects (CPHS) at the University of 
Texas Health Science Center in Houston, Texas prior to data collection. 
 Requests for survey participation were sent by email to hematologists and nurses in 
U.S. HTCs.  Email addresses for potential participants were obtained from the online HTC 
Directory maintained by the CDC.  In total, 570 email addresses were obtained from the 
directory.  Only email addresses for individuals listed as pediatric and/or adult hematologists, 
nurses, and nurse practitioners in the directory were used.  Of the 570 email addresses, 45 were 
returned as undeliverable.  In addition, 9 healthcare providers requested to be excluded from the 
study.  As a result, the total number of invited participants was 516. 
 Data collection occurred between September 2012 and February 2013.  All responses 
were submitted anonymously, and there were no incentives offered to survey participants.  
Complete survey responses were compiled and analyzed in STATA statistical software (version 
10, College Station, TX).  Following completion of the questionnaire, individual participants 
were given a knowledge score based on their responses in the knowledge section.  Scores were 
generated by calculating the number of correct responses divided by the total number of 
questions.  In the attitudes section, participants ranked their response using a 5 point Likert 
scale with 1 representing those who strongly disagree and 5 representing those who strongly 
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agree.  For the purposes of analysis Likert scale responses were grouped together into three 
categories: 1-2, 3, and 4-5 which correspond to the thematic categories: 1)Disagree 2)Agree 
3)Strongly agree.  Similar categorization was done for the second part of the attitude section 
where Likert responses were grouped together into three categories: 1-2, 3, and 4-5 which 
correspond to the thematic categories: 1)Not confident 2)Neither confident nor unconfident 
3)Confident.  Comparisons between demographic features and knowledge and attitudes were 
made using chi-square and one-sided t-tests.  A cut-off p-value of 0.05 or less was used to 
determine statistical significance.  Overall demographic characteristics and study findings that 
were statistically significant are reported. 
 
Results 
 
A total of 117 complete responses and 27 partial responses were received for an overall 
response rate of 22.7%.  This is comparable to response rates in similar studies (9,11).  Partial 
responses were excluded from the analysis.  Of the 117 complete responses, 4 were from 
genetic counselors and 2 were from other allied healthcare professionals.  These responses were 
analyzed separately since they were not part of the targeted population.  Of the remaining 111 
complete responses, 51 (46.0%) were from hematologists and 60 (54.1%) were from nurses.  
Overall, there were 27 male participants (25.5%) and 79 female participants (74.5%) with an 
average age of 60.0 years among the total cohort.  Other demographic characteristics are 
summarized in Table 1. 
A total knowledge score was generated for each participant by dividing the correct 
number of responses by the total number of questions with the highest possible score being 14 
out of 14.  The average score among all participants was 10.5 out of 14 (74.8%).  A minimum 
of 10 correct responses was required to achieve a passing score.  All questions were weighted 
equally.  A total of 81 participants (73.0%) passed the knowledge section with a score of 70% 
or higher and 30 participants (27.0%) scored below 70% in the knowledge section.  Thirty-eight 
out of 51 (74.5%) physicians and 43 out of 61 (71.7%) nurses achieved passing scores of 10 out 
of 14 (71.4%) or more.  The difference in pass rates between physicians and nurses (see Table 
2) was not statistically significant (p = 0.737). 
While the overall scores were not significantly different between physicians and nurses 
there were three questions for which the correct response rate was significantly different 
between the two groups.  Question 1, which asked about the detection rate of F8 genetic testing 
in males with severe hemophilia, and question 11, which asked about the best method for 
determining whether or not a female is a carrier of hemophilia, were more frequently missed by 
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nurses than physicians.  Alternatively, question 10, which asked about the risk of recurrence for 
a family with a simplex case, was more frequently missed by the physician group (Table 3).   
Although knowledge scores were favorable overall, some topics were commonly 
missed in this section by both physicians and nurses.  Specifically, three questions were 
consistently answered incorrectly by over 50% of the study population: questions 4, 6, and 14 
(see Table 4).  These questions covered topics including: preimplantation genetic diagnosis 
(PGD), inheritance, and genetic testing. 
The attitudes section consisted of two parts.  In the first part participants were asked 
about their attitudes regarding genetic counseling services in clinical practice.  The statements 
in this section covered subjects including the provider’s perceived value of genetic counseling 
services, the provider’s comfort level with respect to certain aspects of genetic counseling 
services, and referral practices. The breakdown of questions is summarized in Table 5.  
Question 4, which focused on provider referral practices, indicated that physicians (60.8%) 
were much more likely to refer patients for genetic counseling compared with nurses (36.7%, p 
= 0.027). 
The second part of the attitudes section asked participants how confident they felt about 
providing individual aspects of genetic counseling services.  Specifically, these questions 
included details regarding genetic testing, psychosocial counseling, and insurance issues.  
Participants ranked how confident they felt in their ability to provide information about these 
topics using a 5 point Likert scale where 1 was not at all confident and 5 was very confident.  
The results from this section are summarized in Table 6.  Only question 13 showed a 
statistically significant difference in responses between physicians and nurses.   Responses to 
this question demonstrated that physicians feel more confident than nurses in their ability to 
discuss insurance issues that may arise in the context of genetic testing (p = 0.026).  
Finally, a comparison of knowledge and attitude questions which covered the same 
themes was performed.  There were three major themes present in both the knowledge and 
attitudes sections: inheritance, genetic testing, and carrier testing.  Specifically, among 
providers that incorrectly answered question 6, which asked about the risk of recurrence for a 
carrier female, 79.0% agreed with the statement, “I feel comfortable educating a patient about 
X-linked inheritance” (p = 0.393).  Also, 57.6% of providers who incorrectly answered question 
14, which asked about the best individual to offer genetic testing, agreed with the statement, “I 
would feel comfortable explaining the benefits and limitations of genetic testing for 
hemophilia” (p = 0.052).  In addition, 72.7% of providers who incorrectly answered question 14 
felt confident in their ability to help a patient decide whether to be tested (p = 0.748). 
Lastly, our study assessed the type of access HTCs have to genetic counseling services.  
The majority of participants (91.6%) reported that they have some form of access to genetic 
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counseling services at their center.  A follow-up question gave participants the ability to specify 
what type of access they have (see Table 7).  The most common form of access reported was 
having a genetic counselor that was available as needed (34.7%).  Another 24.5% reported 
having a genetic counselor that attends every clinic.  Still, another 28.6% of participants 
reported having other types of access.  Participants who selected other were asked to specify 
their access.  Responses were categorized and are presented in Box 1.  The most common form 
of access specified by participants was a referral to a separate clinic outside of the HTC 
(84.4%).  Many of these clinics are within the same institution as the HTC, but a separate 
appointment must be made.  Also of note, the majority of providers (n = 83, 75.5%) agreed that 
their patients would benefit from meeting with a genetic counselor as part of their care. 
 
 
Discussion 
 
 This study provides a glimpse into the level of knowledge and the attitudes of providers 
in HTCs across the United States.  The majority of providers have knowledge scores that 
demonstrate an above average level of understanding of the genetics of hemophilia.  In addition, 
the majority of providers report that they feel comfortable providing basic genetic counseling 
services to patients treated at HTCs.  However, newer genetic technologies, such as 
preimplantation genetic diagnosis (PGD), and issues of insurance discrimination are areas in 
which providers not specifically trained in genetic counseling feel less comfortable.   
 
Knowledge 
  
 When asked about PGD, the majority of physicians and nurses (59.5%) incorrectly 
believed that PGD can be useful even if the familial gene mutation is not known.    By 
definition, PGD is used to detect the presence or absence of a mutated gene that is known to 
Box 1  Other forms of access to genetic 
counseling services 
 
By referral within institution (75.0%) 
 
By referral outside of institution (9.4%) 
 
Services provided by other healthcare providers, 
not genetic counselors (9.4%) 
 
Limited access/vacancies (6.3%) 
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cause a genetic disease in a single cell isolated from an embryo (13).  Without having the 
known familial mutation it is not possible to diagnose an embryo prior to implantation.  That 
being said, PGD is a specialized service that is not considered standard of care for patients with 
hemophilia.  As a result, it is reasonable to say that complex issues in genetic medicine, such as 
PGD, lie outside the scope of practice of hematologists and nurses in HTCs; and, therefore, the 
discussion of such issues with patients fall to other specially trained healthcare providers.  Of 
note, 3 out of the 4 genetic counselors that completed the survey answered this question 
correctly.  Out of all of the healthcare providers in HTCs it would seem most likely that patients 
wishing to discuss PGD further should be referred to a genetic counselor when available. 
Another question that was commonly answered incorrectly asked about the chance that, 
in any given pregnancy, a female carrier would have a male with hemophilia.  The majority 
(55.9%) of participants answered incorrectly with the majority selecting 1 in 2 live births as 
their answer.  The correct response is 1 in 4 live births which takes into account both the chance 
for a male baby that also inherits the disease-causing hemophilia mutation.  It is possible that 
responders made the assumption that the affected fetus is male, and thus selected the answer 
choice that corresponded to the 50-50 chance in each pregnancy of a carrier female giving birth 
to a male with hemophilia.  It is likely that this is the case since the majority of participants 
answered the other questions concerning the heredity of hemophilia correctly.  By comparison, 
though, all four of the genetic counselors that responded answered this question correctly.  
While there is most likely not a deficiency in provider knowledge in regards to the inheritance 
of hemophilia, it is important for providers to accurately communicate the risk of recurrence of 
hemophilia to carrier females. 
Lastly, the question which was answered incorrectly most often (61.3%) was question 
14 in the knowledge section.  This question asked which family member would be the best 
person to offer genetic testing.  It is generally agreed that, whenever possible, genetic testing 
should only be offered if the results of the test can be adequately interpreted.  For that reason it 
is best to begin testing in an affected individual (or index case) before proceeding to test 
seemingly unaffected family members in order to eliminate the possibility of receiving an 
uninformative negative test result (14,15).  In our study, the majority of physicians (52.9%) and 
nurses (50.9%) did not choose to offer genetic testing to an affected individual first, but rather 
chose to offer it to the sister of an affected male.  While there is a 50% chance that this 
individual could be a carrier, knowing the affected son’s genetic mutation would be important 
to avoid the possibility of an uninformative negative test result in the sister.  Another 7.8% of 
physicians and 8.8% of nurses chose the mother of an affected son as the best candidate for 
testing.  Offering genetic testing to the mother poses the same risk to receive an uninformative 
negative test result as with the sister of an affected male.  Only after the causative mutation in 
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the family has been identified can genetic screening to other family members, whether they be 
unaffected relatives or obligate carriers, be most informative.  It is worthwhile to point out that 
all four genetic counselors in the study chose to offer testing to the affected individual first.  Our 
finding is not surprising, and similar studies have demonstrated a lack of consistency in the 
practices of providers in the context of genetic testing in individuals with a family history of a 
genetic condition.  For example, a study performed by Mehnert et al. found that approximately 
50% of the gynecologists they surveyed did not recognize the importance of having the genetic 
test results of an index patient when interpreting the test results of an unaffected individual (11).  
Without confirmation of a known familial mutation, negative genetic testing in an unaffected 
individual is not informative because it cannot rule out the possibility of an inherited mutation 
that was undetectable by the testing methodology used.  
 
Attitudes 
 
 Our study aimed to determine the attitudes of providers toward genetic counseling 
services as well as their overall level of confidence in providing these services to patients.  
Previously, a study by Hunter et al. showed that the majority of Canadian physicians felt that 
they possessed adequate genetic knowledge; however, less than 50% of them felt comfortable 
discussing information about genetic services with their patients (6).  Since healthcare providers 
working in HTCs see a large number of patients with hereditary bleeding disorders we wanted 
to assess their attitudes toward educating patients about genetics.  Overall, attitude scores 
among physicians and nurses in our study were high indicating that most hematologists and 
nurses in HTCs feel confident their ability to provide genetic counseling services.  Questions in 
this section focused on common aspects of hemophilia genetics such as counseling a patient 
about genetic testing and helping a patient decided whether or not to pursue genetic testing.  
Other attitude questions aimed to identify the provider’s perceived value of genetic counseling 
services.  The majority of participants indicated that they see value in genetic counseling 
services, especially for first-degree female relatives of affected males. 
In general, physicians felt more comfortable discussing possible insurance implications 
with patients than nurses did.  A study by Acton et al. found that 79% of physicians (family 
practitioners, general internists, obstetrician-gynecologists) felt as though the information 
obtained from genetic testing could be used by employers and insurance companies to 
discriminate against people who had an increased risk for a hereditary cancer (9).  We 
hypothesized that a similar attitude may be present in HTCs since many patients, particularly 
potential carriers, are concerned that having genetic testing will result in insurance 
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discrimination, in the form of increased premiums or gap in coverage due to a pre-existing 
condition. 
Comparison of knowledge and attitude questions addressing the same theme revealed 
discordance between provider knowledge and perception of ability to provide a specific genetic 
counseling service.  While not statistically significant these results illustrate the dilemma that 
arises when providers inaccurately educate/counsel patients when they believe that they are 
providing the correct information.  Specifically, question 13 in the knowledge section asked 
providers to identify an obligate carrier in a pedigree.  This question was compared to the 
provider’s response to the statement: I feel comfortable educating my patient about X-linked 
inheritance.  Twelve out of the 16 (75.0%) providers who incorrectly identified an obligate 
female carrier, somewhat to strongly agreed that they were comfortable discussing inheritance 
with a patient.  This highlights an inconsistency in the accuracy of the information being 
delivered by providers and their recognition of their own abilities.  Two other hereditary 
questions produced similar results (questions 7 and 9 in the knowledge section) when compared 
to the provider’s attitude toward discussing heredity with a patient.  
 
Limitations 
 
Despite our best efforts, this study had a few limitations which must be considered.  
One significant limitation of this study is that it was only distributed to physicians and nurses 
whose email addresses were listed in the CDC’s online directory.  This directory does not 
include the contact information for every provider in every center nationwide, and therefore this 
sample is biased by the fact that it was selectively distributed to providers listed in the directory.  
Also, the number of complete responses is not sufficiently large to produce results with a high 
statistical power.  In addition this study lacked a validated instrument.  Even though our tool 
was modeled after the survey developed and validated by Hofman et al. in the 1990s, it was not 
validated prior to use in the hemophilia community.  As a result, some of the incorrect 
responses may not indicate a deficit of knowledge, but rather a misinterpretation of the question 
or answer choices.     
 
Future Directions 
 
 While this study provides a snapshot of the knowledge and attitudes of hematologists 
and nurses in U.S. HTCs it does not provide insight into the knowledge and attitudes of genetic 
counselors or other providers who are affiliated with HTCs.  Based on the results of our 
questionnaire, the majority of providers (91.6%) report having access to genetic counseling 
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services via a genetic counselor; however, not every HTC has a genetic counselor working on 
site.  A follow-up study assessing the knowledge and attitudes of genetic counselors providing 
genetic counseling services to patients affected by hemophilia would be beneficial to further 
refine the understanding of the level of service available to patients at U.S. HTCs. 
 
Conclusion 
 
 Hematologists and nurses practicing in U.S. HTCs demonstrate sufficient knowledge of 
the genetics of hemophilia, and they generally feel confident in their ability to provide genetic 
counseling services to their patients.  While their knowledge is sufficient, the average 
knowledge score was lower than the 75% that we had anticipated.  In addition, approximately 
23% of physicians and nurses did not demonstrate sufficient knowledge of hemophilia genetics 
in our study.  Based on these findings, there is room for improvement in the genetics education 
of providers working in HTCs.  Interestingly, there is no significant difference in the knowledge 
or attitudes between hematologists and nurses in HTCs; however, there is evidence to suggest 
that there are some topics that physicians feel more comfortable discussing with their patients 
than nurses do.  In addition, level of knowledge has no effect on a provider’s level of 
confidence in providing genetic counseling services.  Finally, many clinics report having 
“access” to a counselor, but the reality is that in clinic, it is oftentimes the nurse or physician 
who is providing genetic counseling services to patients.  Given the inconsistency in provider 
knowledge coupled with the high confidence in one’s ability to counsel patients, it leaves room 
to question whether information about the genetics of hemophilia is being communicated to 
patients in the most appropriate and accurate manner. 
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Appendix: 
Table 1: Summary of demographic characteristics of study population 
Characteristic Physicians Nurses 
n % n % 
Age 
20-29 years 0 0.00% 5 8.33% 
30-39 years 7 13.73% 8 13.33% 
40-49 years 13 25.49% 11 18.33% 
50-59 years 19 37.25% 29 48.33% 
60+ years 12 23.53% 7 11.67% 
Gender 
    
Male 24 47.06% 3 5.00% 
Female 25 49.02% 54 90.00% 
Not disclosed 2 3.92% 3 5.00% 
Patient Population 
    
Adult 12 23.53% 6 10.00% 
Pediatric 20 39.22% 16 26.67% 
Both 16 31.37% 38 63.33% 
Not disclosed 3 5.88% 0 0.00% 
Certified 
    
Yes 47 92.16% 16 26.67% 
No 3 5.88% 31 51.67% 
I don't know or N/A 1 1.96% 13 21.67% 
Years of HTC experience 
    
Less than 1 year 0 0.00% 4 6.67% 
1-5 years 7 13.73% 15 25.00% 
5-10 years 11 21.57% 6 10.00% 
10-20 years 18 35.29% 21 35.00% 
More than 20 years 14 27.45% 14 23.33% 
Not disclosed 1 1.96% 0 0.00% 
Average size of patient population 
   
Less than 50 patients 4 7.84% 14 23.33% 
50-100 patients 20 39.22% 21 35.00% 
100-200 patients 17 33.33% 15 25.00% 
More than 200 patients 9 17.65% 9 15.00% 
Not disclosed 1 1.96% 1 1.67% 
 
Table 2: Pass Rates by provider type 
Score Physician Nurse 
n % n % 
Pass 38 74.51% 43 71.67% 
Fail 13 25.49% 17 28.33% 
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Table 3: Summary of knowledge section, by provider type 
Question (correct 
answer) 
Physician Nurse 
P-value Correct Incorrect Correct Incorrect 
n % n % n % n % 
1. Genetic testing of the F8 gene 
detects mutations in what 
percentage of men with severe 
Hemophilia A? (80-100%) 
38 74.51% 13 25.49% 32 53.33% 28 46.67% 0.021 
2. Which genetic test is most likely 
to be informative in a male with 
severe hemophilia A? (Factor VIII 
intron 22 inversion analysis) 
39 76.47% 12 23.53% 43 71.67% 17 28.33% 0.566 
3. Prenatal diagnosis is most 
informative when a familial gene 
mutation is known. (True) 
48 94.12% 3 5.88% 58 96.67% 2 3.33% 0.660 
4. Preimplantation genetic diagnosis 
can be useful even if the familial 
gene mutation is not known (False) 
20 39.22% 31 60.78% 25 41.67% 35 58.33% 0.793 
5. A female with normal factor VIII 
level (70-140%) cannot be a carrier 
(False) 
49 96.08% 2 3.92% 60 100.00% 0 0.00% 0.209 
6. The chance of a couple having a 
boy with hemophilia if the mother is 
a carrier is: (1 in 4 live births) 
26 50.98% 25 49.02% 23 38.33% 37 61.67% 0.181 
7. The chance of a couple having a 
boy with hemophilia if the father 
has hemophilia and the mother is 
not a carrier is: (None of the above) 
49 96.08% 2 3.92% 59 98.33% 1 1.67% 0.593 
8. An 8 year old boy with 
hemophilia A comes into clinic with 
his mother and 4 year old sister.  
The sister had a blood test which 
revealed a factor level of 60%.  
What do you tell the mother about 
her daughter? (There is no way to 
know . . .) 
45 88.24% 6 11.76% 58 96.67% 2 3.33% 0.140 
9. A boy is diagnosed with severe 
hemophilia after developing 
bleeding symptoms. Genetic testing 
for this boy revealed an intron 22 
inversion mutation in the F8 gene. 
The chance that his mother is a 
carrier for hemophilia is: (90-100%) 
37 72.55% 14 27.45% 40 66.67% 20 33.33% 0.503 
10. If one boy in a family has 
hemophilia but he has no other 
family members with bleeding 
symptoms, the chances that the next 
son of the same parents will have 
hemophilia is: (50%) 
35 68.63% 16 31.37% 52 86.67% 8 13.33% 0.021 
11. In order to determine a female's 
carrier status one should order: 
(Both factor level and genetic 
testing) 
42 82.35% 9 17.65% 39 65.00% 21 35.00% 0.040 
12. In an X-linked condition: (50% 
of the daughters of female carriers 
will be carriers) 
49 96.08% 2 3.92% 58 96.67% 2 3.33% 1.000 
13. Which female family members 
are obligate carriers? (Individual II-
2 only) 
45 88.24% 6 11.76% 50 83.33% 10 16.67% 0.464 
14. Which person in this family 
would be the best candidate to offer 
genetic testing? (Individual III-1) 
20 39.22% 31 60.78% 23 38.33% 37 61.67% 0.924 
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Table 4: Summary of knowledge section 
Question (correct answer) Correct Incorrect 
n % n % 
1. Genetic testing of the F8 gene detects mutations in what 
percentage of men with severe Hemophilia A? (80-100%) 70 63.06% 41 36.94% 
2. Which genetic test is most likely to be informative in a male 
with severe hemophilia A? (Factor VIII intron 22 inversion 
analysis) 
82 73.87% 29 26.13% 
3. Prenatal diagnosis is most informative when a familial gene 
mutation is known. (True) 106 95.50% 5 4.50% 
4. Preimplantation genetic diagnosis can be useful even if the 
familial gene mutation is not known (False) 45 40.54% 66 59.46% 
5. A female with normal factor VIII level (70-140%) cannot be a 
carrier (False) 109 98.20% 2 1.80% 
6. The chance of a couple having a boy with hemophilia if the 
mother is a carrier is: (1 in 4 live births) 49 44.14% 62 55.86% 
7. The chance of a couple having a boy with hemophilia if the 
father has hemophilia and the mother is not a carrier is: (None of 
the above) 
108 97.30% 3 2.70% 
8. An 8 year old boy with hemophilia A comes into clinic with 
his mother and 4 year old sister.  The sister had a blood test 
which revealed a factor level of 60%.  What do you tell the 
mother about her daughter? (There is no way to know . . .) 
103 92.79% 8 7.21% 
9. A boy is diagnosed with severe hemophilia after developing 
bleeding symptoms. Genetic testing for this boy revealed an 
intron 22 inversion mutation in the F8 gene. The chance that his 
mother is a carrier for hemophilia is: (90-100%) 
77 69.37% 34 30.63% 
10. If one boy in a family has hemophilia but he has no other 
family members with bleeding symptoms, the chances that the 
next son of the same parents will have hemophilia is: (50%) 
87 78.38% 24 21.62% 
11. In order to determine a female's carrier status one should 
order: (Both factor level and genetic testing) 81 72.97% 30 27.03% 
12. In an X-linked condition: (50% of the daughters of female 
carriers will be carriers) 107 96.40% 4 3.60% 
13. Which female family members are obligate carriers? 
(Individual II-2 only) 95 85.59% 16 14.41% 
14. Which person in this family would be the best candidate to 
offer genetic testing? (Individual III-1) 43 38.74% 68 61.26% 
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Table 5: Attitudes toward genetic counseling services, by provider type 
Statement 
Physicians Nurses P-
value Disagree Agree Strongly Agree Disagree Agree 
Strongly 
Agree 
1. All mothers of 
sons with 
hemophilia should 
be offered genetic 
counseling. 
3 2 45 4 9 47 0.164 
2. All first degree 
female relatives of 
a patient with 
hemophilia should 
be offered genetic 
counseling. 
3 2 45 5 8 47 0.217 
3. The majority of 
my patients would 
decline genetic 
counseling if it 
were offered to 
them. 
44 3 4 43 11 6 0.119 
4. I commonly 
refer patients for 
genetic counseling. 
11 9 31 16 22 22 0.027 
5. In special 
circumstances I 
refer patients for 
genetic counseling. 
10 8 33 12 14 31 0.534 
6. I only refer 
patients for genetic 
counseling when 
they request it. 
39 4 6 49 5 5 0.875 
7. I would feel 
comfortable 
explaining the 
benefits and 
limitations of 
genetic testing for 
hemophilia. 
2 14 34 10 18 31 0.067 
8. I feel 
comfortable 
educating a patient 
about X-linked 
inheritance. 
3 3 45 4 8 48 0.464 
9. My patients 
would benefit from 
meeting with a 
genetic counselor. 
5 8 38 1 13 45 0.163 
10. My HTC would 
benefit from 
having a genetic 
counselor on staff. 
5 8 37 4 17 36 0.230 
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Table 6: Confidence in ability to provide genetic counseling services, by provider type 
Statement 
Physicians Nurses 
P-value Not 
confident Neither Confident 
Not 
confident Neither Confident 
11. Discuss 
the risks and 
benefits of 
being tested 
for hemophilia 
3 1 47 5 5 48 0.291 
12. Help a 
patient 
understand the 
possible 
implications/u
se of a 
positive test 
result 
3 2 46 6 4 48 0.586 
13. Discuss 
possible 
insurance 
implications 
of having 
genetic testing 
for hemophilia 
8 11 32 22 13 24 0.026 
14. Help a 
patient decide 
whether to be 
tested 
3 5 43 5 15 38 0.063 
15. Help the 
patient cope 
with a positive 
test result 
2 4 44 3 5 51 1.000 
16. Discuss 
the patient's 
fears and 
concerns 
about having a 
child with 
hemophilia 
2 2 46 1 4 53 0.653 
17. Discuss 
the risks and 
benefits of 
being tested 
for hemophilia 
2 3 45 3 4 52 1.000 
18. Help a 
patient 
understand the 
possible 
implications/u
se of a 
positive test 
result 
2 2 45 1 8 50 0.221 
19. Help a 
patient decide 
whether to be 
tested 
2 4 41 4 10 45 0.349 
20. Discuss 
the meaning 
and 
implications 
for patients of 
a negative test 
result 
2 3 45 3 6 50 0.752 
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Table 7: Access to Genetic Counseling Services 
 
Access Physicians Nurses Combined 
Access to Genetic Counseling 
Services n % n % n % 
Yes 45 91.84% 53 91.38% 98 91.59% 
No 4 8.16% 5 8.62% 9 8.41% 
Type of Access 
Genetic counselor attends every 
clinic 15 33.33% 9 16.98% 24 24.49% 
Genetic counselor available by 
phone as needed 
2 4.44% 2 3.77% 4 4.08% 
Genetic counselor available by 
referral to an outside institution 
2 4.44% 6 11.32% 8 8.16% 
Genetic counselor available to 
meet with patient at your clinic as 
needed 
14 31.11% 20 37.74% 34 34.69% 
Other 12 26.67% 16 30.19% 28 28.57% 
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